Kenneth A. Clark

Insider Reports History

Location
Sunnyvale, CA
Signature
/s/ Bhaskar Anand, as Attorney-in-Fact for Kenneth Clark
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth A. Clark:

Company Role Class Num Shares Value Price $ Report Date Ownership
Summit Therapeutics Inc. Director Stock Option (right to buy) 17,796 $155,892 $8.76 02 Jan 2026 Direct
Pulse Biosciences, Inc. Director Stock Option (right to buy) 8,026 20 May 2021 Direct

Insider Reports Filed by Kenneth A. Clark

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SMMT Summit Therapeutics Inc. 02 Jan 2026 2 +$155,893 4 Director 06 Jan 2026, 18:43
SMMT Summit Therapeutics Inc. 02 Jan 2025 2 +$155,977 4 Director 06 Jan 2025, 19:05
SMMT Summit Therapeutics Inc. 11 Oct 2024 1 $0 4 Director 15 Oct 2024, 17:08
SMMT Summit Therapeutics Inc. 02 Jan 2024 2 +$93,049 4 Director 04 Jan 2024, 16:24
SMMT Summit Therapeutics Inc. 03 Jan 2023 2 +$74,148 4 Director 05 Jan 2023, 15:12
SMMT Summit Therapeutics Inc. 03 Jan 2022 2 +$66,116 4 Director 05 Jan 2022, 15:01
SMMT Summit Therapeutics Inc. 07 Oct 2021 2 $0 4 Director 12 Oct 2021, 08:40
SMMT Summit Therapeutics Inc. 07 Oct 2021 0 $0 3 Director 12 Oct 2021, 08:36
PLSE Pulse Biosciences, Inc. 20 May 2021 2 $0 4 Director 21 May 2021, 17:05